Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-08-16

Clinical Trial Update: Long Term Safety of Clopidogrel in Neonates/Infants With Systemic to Pulmonary Artery Shunt Palliation [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating long-term safety of clopidogrel in neonates/infants with systemic-to-pulmonary shunt palliation; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CLOPIDOGREL (CLOPIDOGREL)

Snippet

Sponsor: Sanofi | Conditions: Heart Defects, Congenital | Phase 3 | Status: COMPLETED | Results posted: 2011-08-16